Clinical trials with intraperitoneal cisplatin microspheres for malignant ascites--a pilot study.


A new formulation (CDDP-MS), which is composed of lactic acid oligomer microspheres incorporating cisplatin, has been developed in a dosage form for peritoneal carcinomatosis. In this pilot study, CDDP-MS was used clinically for the treatment of malignant ascites induced by cancers of the digestive organs. Thirteen patients with malignant ascites received… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.